ISRG
Intuitive Surgical, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$366.70
−0.85%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 11.0B | 10.1B | 8.4B | 7.1B | 6.2B |
| Cost of Revenue | 3.7B | 3.4B | 2.7B | 2.4B | 2.0B |
| Gross Profit | 7.4B | 6.6B | 5.6B | 4.7B | 4.2B |
| Operating Expenses | |||||
| R&D Expense | 1.4B | 1.3B | 1.1B | 998.8M | 879.0M |
| SG&A Expense | 2.5B | 2.4B | 2.1B | 2.0B | 1.7B |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 3.9B | 3.7B | 3.3B | 3.0B | 2.6B |
| Cost and Expenses | 7.6B | 7.1B | 6.0B | 5.4B | 4.6B |
| Operating Income (EBIT) | 3.5B | 2.9B | 2.3B | 1.8B | 1.6B |
| Non-Operating | |||||
| Interest Income | 357.0M | 365.9M | 324.9M | 192.1M | 29.7M |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | 357.0M | 365.9M | 324.9M | 192.1M | 29.7M |
| Other Non-Op Income/Expense | 354.6M | 365.9M | 324.9M | 192.1M | 29.7M |
| Non-Operating Income (excl Interest) | (274.3M) | (365.9M) | (324.9M) | (192.1M) | (29.7M) |
| EBT (Pre-Tax Income) | 3.8B | 3.3B | 2.7B | 2.0B | 1.6B |
| Income Tax Expense | 647.9M | 434.8M | 336.3M | 141.6M | 262.4M |
| Bottom Line | |||||
| Net Income | 3.1B | 2.9B | 2.3B | 1.8B | 1.3B |
| Earnings from Cont. Ops | 3.2B | 2.9B | 2.3B | 1.8B | 1.3B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 3.1B | 2.9B | 2.3B | 1.8B | 1.3B |
| Per Share | |||||
| Basic EPS | $8.85 | $8.00 | $6.54 | $5.12 | $3.72 |
| Diluted EPS | $8.79 | $7.87 | $6.42 | $5.03 | $3.65 |
| Revenue Per Share | $31.13 | $28.20 | $23.51 | $20.29 | $17.49 |
| Shares | |||||
| Basic Shares Outstanding | 354.5M | 356.9M | 355.2M | 351.2M | 355.7M |
| Diluted Shares Outstanding | 358.5M | 362.7M | 362.0M | 357.4M | 362.0M |
| Profitability Metrics | |||||
| EBITDA | 4.5B | 4.0B | 3.1B | 2.4B | 2.0B |
| D&A | 780.9M | 677.1M | 462.0M | 402.2M | 365.8M |
| EBIT | 3.7B | 3.3B | 2.7B | 2.0B | 1.6B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026